alternative R&D mechanisms
34 articles related to "alternative R&D mechanisms"
-
Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
Summary Points The current system for the research and development (R&D) of new medicines does not adequately meet the needs of the majority of the world's population. There is...
In Medical Journals / Research Articles – Last updated 16 May 2012
www.msfaccess.org/content/innovation-and-access-medicines-neglected-populations-could-treaty-address-broken -
How a Global R&D Convention Could Fill the Gaps Left by Today's Medical Innovation System
More than a decade after the international medical humanitarian organisation Médecins Sans Frontières (MSF) first called attention to the fatal imbalance in biomedical R&D, our field...
Briefing – Last updated 25 April 2012
www.msfaccess.org/content/how-global-rd-convention-could-fill-gaps-left-todays-medical-innovation-system -
Financing Medical Innovation Through Alternative Mechanisms
How to boost R&D for a low-cost, point-of-care rapid diagnostic test and better drugs for tuberculosis On 11 April 2008, Médecins Sans Frontières (MSF) convened a one-day consultation...
Report – Last updated 11 April 2008
www.msfaccess.org/content/financing-medical-innovation-through-alternative-mechanisms -
The Global Politics of Pharmaceutical Monopoly Power
Every day, Médecins Sans Frontières (MSF) is confronted with the lack of access to adequate or affordable medical tools in the field. We face two major challenges the high cost of existing...
Report – Last updated 16 January 2009
www.msfaccess.org/content/global-politics-pharmaceutical-monopoly-power -
World Health Assembly May 2008
Representatives from more than 150 countries are meeting in Geneva this week at the World Health Assembly. One of their tasks is to complete the work of the Intergovernmental Working Group on Innovation,...
Events & Presentations – Last updated 27 May 2008
www.msfaccess.org/content/world-health-assembly-may-2008 -
Vaccine R&D
Getting developing countries the vaccines they need Vaccine products need to be tailored to developing country needs Two fundamental challenges surround vaccine access and research and development...
Static page – Last updated 25 July 2011
www.msfaccess.org/content/vaccine-rd -
Looking for alternative models
With our medical teams crying out for new and better medical tools, we need to work imaginatively within the constraints of the present system to promote more medical innovation. With increasing governmental...
Static page – Last updated 09 August 2011
www.msfaccess.org/content/looking-alternative-models -
Shaping a new R&D agenda
What’s behind all this is that medical innovation is driven by the health problems of the rich and all but ignores the medical needs of the poor. It’s a system that is extremely costly, too: pharmaceutical...
Static page – Last updated 12 August 2011
www.msfaccess.org/content/shaping-new-rd-agenda -
Medical Innovation: The Issues
What is medical innovation?What is wrong with medical innovation today?The gaps in medical innovationShaping the R&D agendaLooking for alternative models What is medical innovation? Medical...
Static page – Last updated 05 August 2011
www.msfaccess.org/content/medical-innovation-issues -
Medical Innovation Prizes Instead of Monopolies
“Medical Innovation Prizes instead of Monopolies” Innovation Inducement Prizes that de-link the cost of R&D from the price of products to increase access to medicines for patients...
Events & Presentations – Last updated 19 May 2011
www.msfaccess.org/content/medical-innovation-prizes-instead-monopolies
